About Renal Physiology Laboratory, University Health Network
Clinical Trials at Renal Physiology Laboratory, University Health Network
During the past decade, Renal Physiology Laboratory, University Health Network conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Renal Physiology Laboratory, University Health Network"
#1 collaborator was "Toronto General Hospital" with 2 trials as a collaborator, "University of Toronto" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Renal Physiology Laboratory, University Health Network
According to Clinical.Site data, the most researched conditions in "Renal Physiology Laboratory, University Health Network" are
"Focal Segmental Glomerulosclerosis" (1 trials), "Kidney Transplant Recipients" (1 trials), "Post-transplant Diabetes Mellitus" (1 trials), "Type 1 Diabetes Mellitus" (1 trials) and "Type 2 Diabetes" (1 trials). Many other conditions were trialed in "Renal Physiology Laboratory, University Health Network" in a lesser frequency.
Clinical Trials Intervention Types at Renal Physiology Laboratory, University Health Network
Most popular intervention types in "Renal Physiology Laboratory, University Health Network" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Dapagliflozin" (1 trials), "Dapagliflozin 10 MG Oral Tablet" (1 trials), "Empagliflozin 25 MG + Liraglutide 1.8 MG" (1 trials), "Febuxostat" (1 trials) and "Liraglutide 1.8 MG + Empagliflozin 25 MG" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Renal Physiology Laboratory, University Health Network
The vast majority of trials in "Renal Physiology Laboratory, University Health Network" are
4 trials for "All" genders.
Clinical Trials Status at Renal Physiology Laboratory, University Health Network
Currently, there are NaN active trials in "Renal Physiology Laboratory, University Health Network".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Renal Physiology Laboratory, University Health Network,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Renal Physiology Laboratory, University Health Network, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".